股東資訊

Shareholders

For TCI's public announcements and other disclosed information, please visit the Market Observation Post System entering stock code 8436.

April 29, 2023; Unit: Share;%

Name Current shareholding Spouse & Minor Shareholding Shareholding by Nominee Arrangement Name and Relationship Between the Company’s Top 10 Shareholders, or Spouses or Relatives Within the Two Degree of Kinship
Shares % Ratio Shares % Ratio Shares % Ratio

Name

Relationships

Account of
DYDO GROUP HOLDINGS,
INC.
managed by Taipei Fubon Bank

5,880,216 4.97% - - Investment account of Daido Pharmaceutical Corporation managed by Taipei Fubon Bank Parent and subsidiary company

Fubon Life Insurance Co.,Ltd.

5,198,000 4.40% None None

Yong Jiang Investment Co.

5,099,623 4.31% Maxigen Biotech Inc. Same authorized personnel

Yang Guang Investment Co.,Ltd.

4,503,053 3.81% None None

Account of Daido Pharmaceutical Corporation
managed by Taipei Fubon Bank

4,294,409 3.63% - - Investment account of DYDO GROUP HOLDINGS, INC. managed by Taipei Fubon Bank Parent and subsidiary company

Maxigen Biotech Inc.

2,531,000 2.14% - - Yong Jiang Investment Co. Same authorized personnel

Baillie Gifford Global Equity Income Fund
managed by HSBC

2,149,000 1.82% None None

Labor Pension Fund
(The New Fund)

2,141,046 1.81% None None
Ming-Lang Jhuang 1,781,000 1.51% - - - - None None
Ruei-Hua Tsai 1,702,538 1.44% - - - - None None
Loading...
Contact Us

Thank You

For any further question, please feel free to contact us Email:tci-us@tci-bio.com